Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential is a research paper published in Frontiers in Physiology (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: F31 AG069501
NICHD NIH HHS
Grant: P50 HD100549
NIA NIH HHS
Grant: R01 AG061290
NICHD NIH HHS
Grant: F31 HD105363
NICHD NIH HHS
Grant: R01 HD088571
National Institutes of Health
Grant: 5P50HD100549-03
On-Demand Pharmacological Contraception by Blocking ADCY 10
National Institutes of Health
Grant: 5F31AG069501-02
Activation of Soluble Adenylyl Cyclase as a Novel Therapeutic Strategy for the Treatment of Age-Related Neurodegenerative Disorders
National Institutes of Health
Grant: 1F31HD105363-01
Discovery and Characterization of an Endogenous Inhibitor of Soluble Adenylyl Cyclase
Keywords
Sustainable Development Goals